Non-muscle invasive high grade urothelial carcinoma of the bladder. Which factors can influence understaging at the time of radical cystectomy?

Archivio Italiano di Urologia e Andrologia

Volumn 88, Issue 1, 2016, Pages 13-16

  Minardi, Daniele ^a   Milanese, Giulio ^a   Parri, Gianni ^a   Lacetera, Vito ^a   Muzzonigro, Giovanni ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Bladder tumor; High grade bladder carcinoma; Non muscle invasive bladder carcinoma; Understaging.

Indexed keywords

AGE; AGED; ARTICLE; BLADDER DOME; BLADDER TRIGONE; CANCER GRADING; CANCER MORPHOLOGY; CANCER STAGING; CARCINOMA IN SITU; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CYSTECTOMY; DISEASE ASSOCIATION; FEMALE; GENDER; HUMAN; LAMINA PROPRIA; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MULTIPLE CANCER; NON MUSCLE INVASIVE BLADDER CANCER; RISK ASSESSMENT; RISK FACTOR; SURGEON; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMOR INVASION; TUMOR VOLUME; VASCULAR TUMOR; CARCINOMA, TRANSITIONAL CELL; DISEASE COURSE; FACTUAL DATABASE; LYMPH NODE DISSECTION; MIDDLE AGED; PATHOLOGY; PROCEDURES; URINARY BLADDER NEOPLASMS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; DATABASES, FACTUAL; DISEASE PROGRESSION; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM STAGING; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84977765242     PISSN: 11243562     EISSN: 22824197     Source Type: Journal    
DOI: 10.4081/aiua.2016.1.13     Document Type: Article

References (20)

1. Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol. 2009; 27:289-93.
2. Babjuk M, Burger M, Zigeuner R, et al. EAU guidelines on nonmuscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol. 2013; 64:639-53.
3. Ramírez-Backhaus M, Domínguez-Escrig J, Collado A, et al. Restaging Transurethral Resection of Bladder Tumor for High-risk Stage Ta and T1 Bladder Cancer. Curr Urol Rep. 2012; 13:109-14.
4. Poulsen AL, Horn T, Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol. 1998; 160:2015-9.
5. Edge SB, Compton CC. The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010; 17:1471-4.
6. Sauter G, Algaba F, Amin M, et al. Tumours of the urinary system: non-invasive urothelial neoplasias. In: Eble JN, Sauter G, Epstein Jl, Sesterhenn I, eds. WHO classification of classification of tumours of the urinary system and male genital organs. Lyon: IARCC Press, 2004, pp. 29-34.
7. Kirkali Z, Chan T, Manoharan M, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology. 2005; 66:4-34.
8. Ark JT, Keegan KA, Barocas DA, et al. Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy. BJU Int. 2014; 113:894-9.
9. Nieder AM, Brausi M, Lamm D, et al. Management of stage T1 tumors of the bladder: International Consensus Panel. Urology. 2005; 66:108-25.
10. Dutta SC, Smith JA, Shappell SB, et al. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol. 2001; 166:490-3.
11. Hall MC, Chang SS, Dalbagni G, et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol. 2007; 178:2314-30.
12. Montie JE, Clark PE, Eisenberger MA, et al. National Comprehensive Cancer Networkl. Bladder cancer. J Natl Compr Canc Netw. 2009; 7:8-39.
13. McLaughlin S, Shephard J, Wallen E, et al. Comparison of the Clinical and Pathologic Staging in Patients Undergoing Radical Cystectomy for Bladder Cancer. International Braz J Urol. 2007; 33:25-32.
14. Dalbagni G, Herr HW, Reuter VE: Impact of a second transurethral resection on the staging of T1 bladder cancer. Urology. 2002; 60:822-4.
15. Chang SS, Hassan JM, Cookson MS, et al. Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol. 2003; 170:1085-7.
16. Sanchez-Ortiz RF, Huang WC, Mick R, et al. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol. 2003; 169:110-5.
17. Mariappan P, Zachou A, Grigor KM. Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol. 2010; 57:843-9.
18. Zurkirchen MA, Sulser T, Gaspert A, Hauri D. Second transurethral resection of superficial transitional cell carcinoma of the bladder: A must even for experienced urologists. Urol Int. 2004; 72:99-102.
19. Vasdev N, Dominguez-Escrig J, Paez E, et al. The impact of early re-resection in patients with pT1 high-grade non-muscle invasive bladder cancer. Ecancermedicalscience. 2012; 6:269.
20. Solsona E, Iborra I, Rubio J, Casanova J, Almenar S. The optimum timing of radical cystectomy for patients with recurrent highrisk superficial bladder tumour. BJU Int. 2004; 94:1258-62.